当前位置:首页 - 行情中心 - 神州细胞(688520) - 财务分析 - 现金流量表

神州细胞

(688520)

  

流通市值:142.06亿  总市值:150.04亿
流通股本:4.45亿   总股本:4.70亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,034,494,203.29756,194,309.2376,514,303.961,725,605,641.84
  收到的税费返还142,843.86103,057.0788,544.5749,182,974.07
  收到其他与经营活动有关的现金21,558,179.9210,277,374.442,442,053.12131,586,636.01
  经营活动现金流入小计1,056,195,227.07766,574,740.71379,044,901.651,906,375,251.92
  购买商品、接受劳务支付的现金390,014,294.26242,887,830.4100,892,701.06477,314,224.73
  支付给职工以及为职工支付的现金522,836,209.84360,550,005.46156,689,568.42715,282,895.84
  支付的各项税费30,401,613.5420,416,909.478,737,043.1473,002,599.32
  支付其他与经营活动有关的现金510,555,049.85354,748,175.23205,612,253.65916,377,288.41
  经营活动现金流出小计1,453,807,167.49978,602,920.56471,931,566.272,181,977,008.3
  经营活动产生的现金流量净额-397,611,940.42-212,028,179.85-92,886,664.62-275,601,756.38
二、投资活动产生的现金流量:
  收回投资收到的现金2,494,000,0001,424,000,000650,000,0001,690,000,000
  取得投资收益收到的现金3,876,332.931,733,107.23780,049.482,508,219.15
  投资活动现金流入小计2,497,876,332.931,425,733,107.23650,780,049.481,692,508,219.15
  购建固定资产、无形资产和其他长期资产支付的现金142,780,382.3699,534,002.8486,733,460.81216,517,898.77
  投资支付的现金2,529,640,0001,600,000,000700,000,0001,767,970,510.73
  投资活动现金流出小计2,672,420,382.361,699,534,002.84786,733,460.811,984,488,409.5
  投资活动产生的现金流量净额-174,544,049.43-273,800,895.61-135,953,411.33-291,980,190.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金896,000,000896,000,000896,000,000565,000,000
  取得借款收到的现金1,500,109,570.63660,445,236.53214,437,829.422,386,519,740
  筹资活动现金流入小计2,396,109,570.631,556,445,236.531,110,437,829.422,951,519,740
  偿还债务支付的现金1,756,566,950.75991,623,473.6206,461,173.181,789,474,962.19
  分配股利、利润或偿付利息支付的现金84,684,759.0649,178,323.2620,296,291.51111,830,872.1
  支付其他与筹资活动有关的现金35,030,731.6930,398,710.13540,931.9827,176,331.72
  筹资活动现金流出小计1,876,282,441.51,071,200,506.99227,298,396.671,928,482,166.01
  筹资活动产生的现金流量净额519,827,129.13485,244,729.54883,139,432.751,023,037,573.99
四、汇率变动对现金及现金等价物的影响-51,430.76-53,129.893,134.43-58,686.45
五、现金及现金等价物净增加额-52,380,291.48-637,475.81654,302,491.23455,396,940.81
  加:期初现金及现金等价物余额770,330,864.6770,330,864.6770,330,864.6314,933,923.79
  期末现金及现金等价物余额717,950,573.12769,693,388.791,424,633,355.83770,330,864.6
补充资料:
  净利润--377,200,763.09--566,202,185.71
  资产减值准备-12,406,663.68-19,642,764.22
  固定资产和投资性房地产折旧-65,104,858.91-132,843,564.09
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-65,104,858.91-132,843,564.09
  无形资产摊销-13,302,379.88-22,009,794.88
  长期待摊费用摊销-7,833,787.6-14,608,190.25
  处置固定资产、无形资产和其他长期资产的损失----5,814.16
  固定资产报废损失-998.59--56,044.65
  公允价值变动损失-6,667,126.34--10,323,313.36
  财务费用-42,681,060.92-88,997,866.54
  投资损失--1,262,830.55--1,253,907.51
  递延所得税--1,734,126.76-2,580,828.34
    递延所得税负债增加--1,734,126.76-2,580,828.34
  存货的减少--31,749,261.09--83,384,704.4
  经营性应收项目的减少-49,092,036.55-174,258,043.8
  经营性应付项目的增加--7,046,093.05--34,936,186.73
  其他-713,587.29--63,955,983.04
  现金的期末余额-769,693,388.79-770,330,864.6
  减:现金的期初余额-770,330,864.6-314,933,923.79
  现金及现金等价物的净增加额--637,475.81-455,396,940.81
公告日期2026-10-312026-08-292026-04-302026-04-23
审计意见(境内)标准无保留意见
TOP↑